Sign in

NCT06783413Completed

Effects of Laughter Yoga on Fatigue, Sleep Quality and Psychological Well-Being in Patients With Multiple Sclerosis: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 31 Dec 2025

Brief summary (registry, in English)

This study is planned to evaluate the effects of laughter yoga applied to patients with multiple sclerosis on fatigue, sleep quality and psychological well-being. Although there are studies in the national and international literature that separately address the effects of laughter therapy on fatigue, sleep quality and psychological well-being, no studies have been found that address the effects of laughter therapy on fatigue, sleep quality and psychological well-being in patients with multiple sclerosis. This study is expected to make a significant contribution to the literature as it is the first experimental study to evaluate the effects of laughter therapy and laughter yoga applied to patients with multiple sclerosis on fatigue, sleep quality and psychological well-being. It is also thought that this study can guide studies to be conducted with other parameters. This study is planned to evaluate the effects of laughter yoga applied to patients with multiple sclerosis on fatigue, sleep quality and psychological well-being. Research Hypothesis H1: Laughter yoga reduces the fatigue level of multiple sclerosis patients compared to the control group. H2: Laughter yoga increases the sleep quality of multiple sclerosis patients compared to the control group. H3: Laughter yoga increases the effect of laughter yoga on psychological well-being of multiple sclerosis patients compared to the control group. Variables of the Study Dependent Variables: Introductory Information Form, Fatigue Severity Scale-YSQ, Pittsburgh Sleep Quality Index (PSQI), Psychological Well-Being Scale (PWSS) and Expanded Disability Status Scale (EDSS) will be used. Independent Variables: Laughter Yoga

Status (registry)
Completed
Study type
Interventional
Enrollment
40 (actual)
First submitted
14 Jan 2025
Start date
15 Apr 2025
Primary completion date
30 May 2025
Lead sponsor
Tokat Gaziosmanpasa University
NCT number
NCT06783413

What you commit to

  • Study type: Interventional
  • Participants enrolled: 40
  • From 15 Apr 2025 to the primary completion date, 30 May 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having previously experienced laughter yoga

Other illness

  • Having a diagnosis of cognitive or mental disorder
  • Having a history of surgery in the last 3 months

Other

  • Having communication problems

Who the study is looking for

  • Being between the ages of 18-65
  • Being literate
  • Being diagnosed with MS
  • Not having had an attack in the last month
  • Being under 6.5 on the Expanded Disability Status Scale (EDSS)
  • Not having a diagnosis of cognitive or mental disorder
  • Being willing to participate in the study
  • The patient has internet access
  • Not having incontinence

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Tokat Gaziosmanpaşa University
Coordinator of this site? Confirm its status
Tokat ProvinceTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.